Back
Kymera Therapeutics Vs. MarineMax Industry Stock Comparison
Buy
67
KYMR
Kymera Therapeutics
Last Price:
47.67
Seasonality Move:
42.01%
Buy
63
HZO
MarineMax
Last Price:
30.51
Seasonality Move:
17.68%
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $48.63. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
MarineMax (HZO)
is a Buy
Is MarineMax a Buy, Sell or Hold?
- The current MarineMax [HZO] share price is $30.82. The Score for HZO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- HZO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $48.63
The current trend is moderately bearish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 51.95 | Buy |
| Chaikin Money Flow: | -280166 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.54 - 49.8) | Buy |
| Bollinger Bands (100): | (38.88 - 49.8) | Buy |
HZO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.49 | Sell |
| Chaikin Money Flow: | -178557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.22 - 32.22) | Buy |
| Bollinger Bands (100): | (29.68 - 34.52) | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.45 | Sell |
| 20-day SMA: | 48.47 | Buy |
| 50-day SMA: | 47.25 | Buy |
| 200-day SMA: | 40.53 | Buy |
| 8-day EMA: | 49.42 | Sell |
| 20-day EMA: | 48.46 | Buy |
| 50-day EMA: | 47.02 | Buy |
| 200-day EMA: | 40.23 | Buy |
HZO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.26 | Sell |
| 20-day SMA: | 30.56 | Buy |
| 50-day SMA: | 31.89 | Sell |
| 200-day SMA: | 31.02 | Sell |
| 8-day EMA: | 31.22 | Sell |
| 20-day EMA: | 31.05 | Sell |
| 50-day EMA: | 31.43 | Sell |
| 200-day EMA: | 31.57 | Sell |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.
MarineMax Earnings Growth & HZO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.10 per share, and an increase next year of $0.17 per share.
Kymera Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MarineMax Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||